Vitrolife Group (VITR) Handelsbanken Nordic Small & Mid Cap Seminar 2024 presentation summary

Market opportunity and industry trends

• Infertility affects 1 in 6 people globally, with less than 1% of annual births via IVF and a 5-7% estimated cycle growth in coming years.

• IVF birth rates have improved for patients under 43, but less than half of embryos transferred result in pregnancy.

• Access and affordability are improving, with significant government support in countries like China and Japan, but costs remain high at $15,000–$30,000 per cycle.

Strategic vision and portfolio

• Mission is to be the leading global partner in reproductive health, with a vision to enable people to fulfill the dream of having a healthy baby.

• Portfolio covers every step of the IVF journey, including labware, genetic testing, cryopreservation, and digital tools.

• Operates in 125 markets with around 1,100 employees and 2023 sales of 3,512 MSEK.

Market dynamics and value creation

• Growth in demand, labor shortages, and clinic consolidation drive the need for automation, digitalization, and standardization.

• Diverse portfolio and digital solutions address regional differences and empower patients.